A new study published in the journal eGastroenterology provides an updated assessment of the diagnosis, pathophysiology, and treatment of hepatorenal syndrome-acute kidney injury (HRS-AKI). This ...

Mission Therapeutics has divested MTX652, a Phase 2-ready selective USP30 inhibitor for Acute Kidney Injury (AKI), to ASX-listed renal specialist ...

Increases in serum creatinine similar to patients who received usual care ...

Understanding and categorizing the various types of tubulointerstitial responses in acute kidney injury (AKI) may lead to the development of new treatments for the condition, according to Yale School ...

A recent study published in the Journal of the American Medical Association revealed that acute kidney injury (AKI) in ...

Sponsors educational summit of leading pediatric AKI health care experts Announces best practices webinar to further advance new treatment ...

NURTuRE-AKI is a novel observational study that collects longitudinal data and biological samples from fully consented acute kidney injury ("AKI") patients, developed as part of a research consortium ...

Dimerix Limited (ASX: DXB, "Dimerix") a clinical-stage biopharmaceutical company developing kidney disease treatments, is pleased to announce that it has acquired DMX-652 for all indications from ...

Compared with no treatment, aspirin use was associated with an increased risk for acute kidney injury (AKI) in critical patients with chest trauma, a new cohort study revealed. Nonsteroidal ...

Five women in Rajasthan seeking help after alleged postpartum kidney failure have drawn attention to postpartum acute kidney ...